97052171 - NEOFORDEX

Information

• Trademark
• 97052171

• Source

• Serial Number

  97052171

• Registration Number

  6888402

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  September 29, 2021
  3 years ago

• Registration Date

  November 01, 2022
  2 years ago

• Transaction Date

  November 01, 2022
  2 years ago

• Status Date

  November 01, 2022
  2 years ago

• Published for Opposition Date

  August 16, 2022
  2 years ago

• Location Date

  November 01, 2022
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  ENGEL, MICHAEL L

• Attorney Docket Number

  2655-69

  Attorney Name

  Pina Campagna

  Law Office Assigned Location Code

  L70

• Owners

  • LABORATOIRES C.T.R.S.

Case File Statements

• GS0051: Pharmaceutical and veterinary products for treating progression of chronic diseases, proliferative diseases, and for treating rheumatological diseases; pharmaceutical and veterinary products for treating oncological diseases, namely, colon cancer, rectum cancer, breast cancer, prostate cancer, pancreatic cancer, gastric cancer, thyroid cancer, larynx cancer, liver cancer, uterine cancer, cervical cancer, esophagus cancer, ovarian cancer, lung cancer, pleural cancer, oral cavity cancer, kidney cancer, bladder cancer, testicular cancer, melanoma, lymphatic cancer, hematopoietic cancer, carcinoma, sarcoma, nervous system cancer, namely, primary tumors; pharmaceutical and veterinary products for treating onco-haematological diseases, namely, lymphomas, namely, Hodgkin's disease and non-Hodgkin lymphomas, lymphadenopathy, myeloma, namely, multiple myeloma, and leukemia; pharmaceutical and veterinary products for treating haematological diseases, namely, amyloses, and purpura, namely, thrombocytopenic purpura; pills, capsules, tablets, and powders pertaining to healthy diet for use in treating oncological diseases; chemical preparations for medical and pharmaceutical use for treating progression of chronic diseases, proliferative disease, and for treating rheumatological diseases; chemical preparations for medical and pharmaceutical use for treating oncological diseases, namely, colon cancer, rectum cancer, breast cancer, prostate cancer, pancreatic cancer, gastric cancer, thyroid cancer, larynx cancer, liver cancer, uterine cancer, cervical cancer, esophagus cancer, ovarian cancer, lung cancer, pleural cancer, oral cavity cancer, kidney cancer, bladder cancer, testicular cancer, melanoma, lymphatic cancer, hematopoietic cancer, carcinoma, sarcoma, nervous system cancer, namely, primary tumors; chemical preparations for medical and pharmaceutical use for treating onco-haematological diseases, namely, lymphomas, namely, Hodgkin's disease and non-Hodgkin lymphomas, lymphadenopathy, myeloma, namely, multiple myeloma, and leukemia. chemical preparations for medical and pharmaceutical use for treating haematological diseases, namely, amyloses, and purpura, especially thrombocytopenic purpura

Case File Event Statements

• 11/1/2022 - 2 years ago

  15 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 11/1/2022 - 2 years ago

  14 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/16/2022 - 2 years ago

  13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/16/2022 - 2 years ago

  12 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/27/2022 - 2 years ago

  11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/14/2022 - 2 years ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/13/2022 - 2 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/12/2022 - 2 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/12/2022 - 2 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/5/2022 - 2 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/5/2022 - 2 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/5/2022 - 2 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/29/2022 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 10/27/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 10/2/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP